HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY
A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Li, C., Lu, N., He, Z. et al. A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Ann Surg Oncol 29, 7685–7693 (2022). https://doi.org/10.1245/s10434-022-12034-w
Synopsis: To predict pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer, the authors constructed a preoperative and noninvasive tool based on both tumoral and peritumoral magnetic resonance imaging radiomic features, with AUCs over 0.9 in both cohorts.
Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances—A Systematic Review of Oncological Outcomes
Ronsini, C., Solazzo, M.C., Bizzarri, N. et al. Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances—A Systematic Review of Oncological Outcomes. Ann Surg Oncol 29, 8346–8358 (2022). https://doi.org/10.1245/s10434-022-12436-w
Synopsis: Fertility-sparing treatments (FST) have played a crucial role in early-stage cervical cancer ECC management. The guidelines have recognized various approaches, but no consensus for the EEC> 2cm. The aim of this systematic review is to collect the literature evidence regarding the management of this type of patient.
Listen to the ASO's new podcast, Speaking of SurgOnc®
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).
The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.
Listen to the podcast here.
ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.